April Armstrong, MD, MPH
Clinical Board Chairs
Co-Director
Professor and Chief, Division of Dermatology, University of California Los Angeles (UCLA), Los Angeles, CA
West/Pacific, CA
Areas of Expertise
Psoriasis
Biologics
JAK Inhibitors
TYK2 Inhibitors
Atopic Dermatitis
Topical Therapies
Disclosure
Advisory Board: Incyte, Regeneron, UCB
Grant/Research Support: Alumis, Bristol-Myers Squibb, Galderma, Janssen, Novartis, Takeda
Consultant: Abbvie, Amgen, Arcutis, Bristol-Myers Squibb, Dermavant Sciences, Eli Lilly and Company, Galderma, Janssen, LEO Pharma, Novartis, Pfizer, Regeneron, Sanofi, UCB
Speakers’ Bureau or Honoraria: Janssen, Eli Lilly and Company, Galderma, Regeneron, Ortho Derm
Other Financial Benefit: Data Safety Monitoring Board: Boehringer Ingelheim